Open access
Aug 2026
Clinical spectrum and survival outcomes of malignancies in pediatric patients with inborn errors of immunity
Early immunologic evaluation and timely, individualized consideration of HSCT may support optimized management in children and adolescents, in whom cancer may be the first manifestation of IEI.
Nazli Deveci Demirbas, Z. Haskoloğlu, Tutku Baylan et al.
· Frontiers in Immunology · 0 citations